Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Feb;49(1):5-6.
doi: 10.1007/s12160-014-9644-5.

Reminder systems, not education, improve glaucoma adherence: a comment on Cook et al

Affiliations
Comment

Reminder systems, not education, improve glaucoma adherence: a comment on Cook et al

Harry A Quigley. Ann Behav Med. 2015 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Author Harry Quigley declares that he has no conflict of interest. He is a consultant for 3 companies that make ophthalmic products or drugs (Zeiss, AC Immune, Sensimed) and is on the scientific advisory board of Graybug, Inc.

Comment on

References

    1. Cook PF, Schmiege SJ, Mansberger S, Kammer J, Fitzgerald T, Kahook MY. Predictors of Adherence to Glaucoma Treatment in a Multi-Site Study. Ann Behav Med, 2015. DOI: To be added. - PMC - PubMed
    1. Friedman DS, Jampel H, Congdon N, Miller R, Quigley HA. The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol. 2007;143:699–701. - PubMed
    1. Sleath B, Blalock SJ, Covert D, Skinner AC, Muir KW, Robin AL. Patient race, reported problems in using glaucoma medications, and adherence. ISRN Ophthalmol. 2012. October 15;2012:902819. - PMC - PubMed
    1. Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS. Adherence with topical glaucoma medication monitored electronically: The Travatan Dosing Aid Study. Ophthalmology 2009;116:191–9. - PubMed
    1. Friedman DS, Quigley HA, Gelb L, Tan J, Margolis J, Shah SN, Kim EE, Zimmerman T, Hahn SR. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48:5052–7. - PubMed